C1QTNF7 and metabolic syndrome: In obese humans and Metabolic Syndrome (MetS) patients, circulating CTRP7 levels were significantly elevated and positively correlated with BMI, glucose, insulin, insulin resistance index, hemoglobin A1c, and triglyceride levels, which may be a novel biomarker related to metabolic diseases (23, 24).